Clinical Trial: the diagnostic value of combined detection of LRG1, VEGF, MCP-1, and KIM-1 in the early stage of diabetic nephropathy and its correlation with pathological characteristics (China)

Posted On: 2026-09-08

China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'the diagnostic value of combined detection of LRG1, VEGF, MCP-1, and KIM-1 in the early stage of diabetic nephropathy and its correlation with pathological characteristics'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131824

Registration Time: 2026/09/07

Type: Observational study

Primary Sponsor: Zhejiang Provincial People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=288143

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: the diagnostic value of combined detection of LRG1, VEGF, MCP-1, and KIM-1 in the early stage of diabetic nephropathy and its correlation with pathological characteristics (China)